NFKB1 and atherosclerosis: Vinpocetine influences many steps in atherosclerosis and ischemic stroke by affecting endothelial cells, VSMCs, macrophages, and microglia, and by inhibiting the release of many inflammatory mediators by suppressing the IKK/NF-κB pathway.